Return to
series page to register.
Invasive breast cancer is a major cause of disease and death among women. In particular, triple-negative breast cancer (TNBC), a subtype of breast cancer that is clinically aggressive with high rates of metastasis and recurrence, disproportionately affects women of African descent and carriers of germline BRCA and PALB2 mutations. Amongst younger patients with breast cancer, the TNBC subtype was associated with higher pathologic stage and worse long-term survival.
In this webinar, Dr. Rosner will present some of the key challenges we face in trying to eliminate metastatic breast cancer. She will present different strategies for trying to effectively target metastatic disease and, based upon her work, some novel approaches to addressing these problems.
Key Topics:
- An understanding of the genetic and non-genetic drivers of metastatic breast cancer
- Explore the limitations of current approaches to treatment of metastatic breast cancer
- Consider other strategies for targeting breast cancer